Neurological Biomarker Market Scope And Analysis

  • Report Code : TIPRE00003515
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Neurological Biomarkers Market Scope and Analysis Report by 2031

Buy Now


Neurological Biomarkers Market Report Scope

Report Attribute Details
Market size in 2021 US$ 5400.90 Million
Market Size by 2031 US$ 18600.93 Million
Global CAGR (2023 - 2031) 13.6%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Product
  • Proteomics Biomarker
  • Genomics Biomarker
  • Metabolomics Biomarker
  • Imaging Biomarker
By Application
  • Alzheimer's Disease
  • Parkinson's Disease
  • Schizophrenia
  • Huntington's Disease
  • Spinal Muscular Atrophy
By End User
  • Pharmaceutical and Biotechnology Companies
  • Clinical Diagnostics
  • Research Organizations
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Thermo Fisher Scientific Inc
  • Abbott
  • Myriad Genetics Inc
  • Bio Rad Laboratories Inc
  • Qiagen
  • Banyan Biomarkers Inc
  • Immunarray Pvt Ltd
  • Quest Diagnostics Incorporated
  • PerkinElmer Inc
  • Merck Millipore
  • Neurological Biomarkers Market News and Recent Developments

    The Neurological Biomarkers Market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for neurological biomarkers and strategies:

    • In April 2021, Quantrix Corp., announced a webinar with leading industry experts to discuss neurological advancements related to the ultra-sensitive quantification of pTau181, pTau217, pTau231, and other neurological biomarkers (Source: Quantrix Corp, Press Release, 2021)   

    Neurological Biomarkers Market Report Coverage and Deliverables

    The “Neurological Biomarkers Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

    • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
    • Market dynamics such as drivers, restraints, and key opportunities
    • Key future trends
    • Detailed PEST/Porter’s Five Forces and SWOT analysis
    • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
    • Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
    • Detailed company profiles